BGI and Danish Researchers Complete 2,000 Exomes for Metabolic Disease Project | GenomeWeb

By Julia Karow

This article was originally published Nov. 8.

WASHINGTON, DC – In an attempt to determine the role of low-frequency coding variants in common metabolic diseases like type-2 diabetes and obesity, researchers at BGI in Shenzhen and in Denmark have sequenced the exomes of 1,000 Danish disease samples and 1,000 controls, as well as validated interesting variants in another 10,000 disease samples and 7,000 controls.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.